2269
COM:WUXIBIOLOGICS
WuXi Biologics
- Stock
Last Close
16.08
14/11 01:29
Market Cap
46.18B
Beta: -
Volume Today
68.06M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
cost and expenses | 280.93M - | 497.16M 76.97% | 761.80M 53.23% | 1.18B 55.18% | 1.84B 55.67% | 2.93B 59.03% | 3.85B 31.58% | 6.83B 77.24% | 10.47B 53.40% | 12.92B 23.41% | |
cost of revenue | 208.60M - | 376.32M 80.41% | 599.92M 59.42% | 958.27M 59.73% | 1.52B 58.27% | 2.32B 53.28% | 3.08B 32.46% | 5.46B 77.34% | 8.54B 56.46% | 10.21B 19.45% | |
depreciation and amortization | 41.06M - | 62.71M 52.73% | 123.53M 96.98% | 122.75M 0.63% | 143.77M 17.13% | 221.37M 53.97% | 303.01M 36.88% | 481.78M 59.00% | 800.67M 66.19% | 718.63M 10.25% | |
ebitda | 93.88M - | 124.94M 33.09% | 325.07M 160.18% | 471.39M 45.01% | 1.02B 116.42% | 1.33B 30.49% | 2.06B 54.83% | 4.34B 110.51% | 6.96B 60.41% | 4.65B 33.17% | |
eps | 0.01 - | 0.01 6.50% | 0.04 216.79% | 0.08 92.77% | 0.17 112.50% | 0.27 58.82% | 0.43 59.26% | 0.81 88.37% | 1.06 30.86% | 0.77 27.36% | |
eps diluted | 0.01 - | 0.01 6.50% | 0.04 216.79% | 0.07 76.63% | 0.16 118.28% | 0.25 56.25% | 0.40 60.00% | 0.77 92.50% | 1.01 31.17% | 0.78 22.77% | |
general and administrative expenses | 42.52M - | 70.38M 65.53% | 93.71M 33.15% | 134.02M 43.01% | 227.72M 69.92% | 367.29M 61.29% | 511.44M 39.25% | 875.93M 71.27% | 1.27B 44.94% | 1.50B 17.78% | |
gross profit | 123.25M - | 180.72M 46.62% | 389.11M 115.31% | 660.56M 69.76% | 1.02B 54.08% | 1.66B 62.99% | 2.53B 52.70% | 4.83B 90.64% | 6.72B 39.25% | 6.83B 1.55% | |
income before tax | 49.01M - | 65.40M 33.44% | 175.85M 168.87% | 303.69M 72.70% | 737.72M 142.92% | 1.13B 52.72% | 1.97B 74.48% | 3.99B 103.13% | 5.36B 34.18% | 4.17B 22.10% | |
income tax expense | 7.03M - | 20.89M 197.03% | 34.75M 66.32% | 51.06M 46.93% | 107.26M 110.06% | 116.30M 8.43% | 273.07M 134.80% | 484.54M 77.44% | 807.87M 66.73% | 603.18M 25.34% | |
interest expense | 2.56M - | 2.53M 0.98% | 24.16M 854.37% | 35.69M 47.76% | 138.59M 288.29% | 19.61M 85.85% | 42.73M 117.96% | 39.19M 8.29% | 64.38M 64.28% | ||
interest income | 60K - | 66K 10% | 413K 525.76% | 8.75M 2,017.68% | 78.39M 796.34% | 63.86M 18.54% | 80.86M 26.63% | 58.03M 28.24% | 107.47M 85.22% | 60.69M 43.53% | |
net income | 41.98M - | 44.51M 6.03% | 141.10M 217.01% | 252.63M 79.05% | 630.59M 149.61% | 1.01B 60.77% | 1.69B 66.59% | 3.39B 100.63% | 4.42B 30.45% | 3.40B 23.09% | |
operating expenses | 72.34M - | 120.84M 67.06% | 161.88M 33.96% | 223.92M 38.32% | 323.62M 44.52% | 601.77M 85.95% | 771.43M 28.19% | 1.36B 76.84% | 1.93B 41.15% | 2.71B 40.98% | |
operating income | 52.82M - | 62.23M 17.82% | 201.54M 223.87% | 348.64M 72.99% | 876.43M 151.38% | 1.11B 26.63% | 1.76B 58.41% | 3.86B 119.38% | 6.16B 59.69% | 3.93B 36.15% | |
other expenses | -9.51M - | -2.73M 71.34% | -438K 83.93% | -12.20M 2,685.62% | -115.82M 849.29% | -102.25M 11.72% | -138.15M 35.12% | -137.93M 0.16% | -189.66M 37.51% | ||
research and development expenses | 35.02M - | 39.74M 13.47% | 53.28M 34.07% | 74.48M 39.78% | 169.29M 127.29% | 259.65M 53.38% | 303.73M 16.98% | 501.58M 65.14% | 682.82M 36.13% | 785.82M 15.09% | |
revenue | 331.85M - | 557.04M 67.86% | 989.03M 77.55% | 1.62B 63.68% | 2.53B 56.56% | 3.98B 57.18% | 5.61B 40.88% | 10.29B 83.35% | 15.27B 48.38% | 17.03B 11.56% | |
selling and marketing expenses | 4.30M - | 13.45M 212.50% | 15.33M 13.97% | 27.62M 80.23% | 42.43M 53.61% | 77.08M 81.66% | 94.42M 22.49% | 124.65M 32.02% | 162.91M 30.70% | 294.01M 80.47% | |
selling general and administrative expenses | 46.82M - | 83.83M 79.04% | 109.04M 30.08% | 161.64M 48.24% | 270.15M 67.13% | 444.37M 64.49% | 605.85M 36.34% | 1.00B 65.15% | 1.43B 43.17% | 2.09B 45.61% | |
total other income expenses net | -3.81M - | 3.17M 183.39% | -25.69M 909.48% | -44.96M 74.98% | -138.71M 208.54% | 16.77M 112.09% | 207.64M 1,137.81% | 136.12M 34.44% | -801.41M 688.75% | 241.06M 130.08% | |
weighted average shs out | 3.40B - | 3.40B 0% | 3.40B 0% | 3.22B 5.29% | 3.63B 12.70% | 4.00B 10.06% | 4.21B 5.30% | 4.17B 0.84% | 4.17B 0.02% | 4.40B 5.45% | |
weighted average shs out dil | 3.40B - | 3.40B 0% | 3.40B 0% | 3.48B 2.31% | 3.94B 13.23% | 4.00B 1.41% | 4.21B 5.30% | 4.42B 5.05% | 4.38B 1.04% | 4.35B 0.62% |
All numbers in (except ratios and percentages)